scispace - formally typeset
T

Thomas W. Stephens

Researcher at Eli Lilly and Company

Publications -  19
Citations -  10660

Thomas W. Stephens is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Leptin & Leptin receptor. The author has an hindex of 12, co-authored 19 publications receiving 10379 citations.

Papers
More filters
Journal ArticleDOI

Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans

TL;DR: Serum leptin concentrations are correlated with the percentage of body fat, suggesting that most obese persons are insensitive to endogenous leptin production.
Journal ArticleDOI

The role of neuropeptide Y in the antiobesity action of the obese gene product.

TL;DR: In this paper, a truncated inactive protein was found to suppress food intake and decrease body weight in normal and ob/ob mice but not db/db (diabetic) mice, which are thought to lack the appropriate receptor.
Journal ArticleDOI

Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects.

TL;DR: The nocturnal rise in leptin observed in the present study resembles those reported for prolactin, thyroid-stimulating hormone, and free fatty acids and is speculated to have an effect in suppressing appetite during the night while sleeping.
Journal ArticleDOI

Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting.

TL;DR: In lean subjects with relatively low adipose tissue, the majority of circulating leptin is in the bound form and thus may not be available to brain receptors for its inhibitory effects on food intake both under normal and food deprivation states.
Journal ArticleDOI

Regulation of Expression of ob mRNA and Protein by Glucocorticoids and cAMP

TL;DR: It is shown that leptin treatment down-regulates endogenous adipose ob mRNA, however, treatment of isolated rat adipocytes with 100 ng/ml human or murine leptin had no direct effect on expression of endogenous ob RNA, suggesting that leptin may be able to down- Regulate its own expression by an indirect, non-autocrine mechanism.